Polaris Financial Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Polaris Financial Partners’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.07M	Buy	+15,041	New	+$918K	0.48%	33

Polaris Financial Partners's GNOM Position: Q3 2026 in Review

Polaris Financial Partners opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q3 2026: 15,041 shares worth $1.07M. The stake represents 0.48% of the portfolio and ranks #33 among its holdings.

1 fund tracked by Wall St. Rank holds GNOM as of Q3 2026.

Polaris Financial Partners held 15,041 shares of Global X Genomics & Biotechnology ETF worth $1.07M as of Q3 2026.
Global X Genomics & Biotechnology ETF was a new Polaris Financial Partners position in Q3 2026.
Global X Genomics & Biotechnology ETF made up 0.48% of Polaris Financial Partners's portfolio in Q3 2026, its #33 holding.
1 fund tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.

Based on Polaris Financial Partners's 13F filing for Q3 2026, filed 2 Oct 2026.